DSC Advisors L.P. lowered its position in HCA Healthcare Inc (NYSE:HCA) by 15.8% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 160,432 shares of the company’s stock after selling 30,058 shares during the quarter. HCA Healthcare accounts for approximately 8.2% of DSC Advisors L.P.’s investment portfolio, making the stock its largest position. DSC Advisors L.P.’s holdings in HCA Healthcare were worth $14,092,000 at the end of the most recent quarter.
Several other institutional investors have also recently added to or reduced their stakes in the company. Nationwide Fund Advisors boosted its holdings in HCA Healthcare by 7.7% in the third quarter. Nationwide Fund Advisors now owns 423,184 shares of the company’s stock valued at $33,681,000 after acquiring an additional 30,220 shares during the last quarter. Raymond James Financial Services Advisors Inc. boosted its holdings in HCA Healthcare by 7.7% in the third quarter. Raymond James Financial Services Advisors Inc. now owns 47,354 shares of the company’s stock valued at $3,769,000 after acquiring an additional 3,392 shares during the last quarter. Crossmark Global Holdings Inc. bought a new stake in HCA Healthcare in the third quarter valued at approximately $553,000. Sei Investments Co. boosted its holdings in HCA Healthcare by 11.0% in the third quarter. Sei Investments Co. now owns 92,053 shares of the company’s stock valued at $7,328,000 after acquiring an additional 9,122 shares during the last quarter. Finally, Retirement Systems of Alabama boosted its holdings in HCA Healthcare by 1.0% in the third quarter. Retirement Systems of Alabama now owns 140,210 shares of the company’s stock valued at $11,159,000 after acquiring an additional 1,450 shares during the last quarter. 73.48% of the stock is owned by institutional investors.
A number of research firms have issued reports on HCA. Cantor Fitzgerald restated a “buy” rating and set a $115.00 price target on shares of HCA Healthcare in a report on Tuesday, January 30th. BMO Capital Markets increased their price target on HCA Healthcare from $96.00 to $115.00 and gave the stock an “outperform” rating in a report on Thursday, February 1st. They noted that the move was a valuation call. Morgan Stanley increased their price target on HCA Healthcare from $84.00 to $91.00 and gave the stock an “underweight” rating in a report on Thursday, February 1st. Sanford C. Bernstein restated a “market perform” rating and set a $116.00 price target (up from $105.00) on shares of HCA Healthcare in a report on Thursday, February 1st. Finally, Leerink Swann increased their price target on HCA Healthcare from $105.00 to $120.00 and gave the stock an “outperform” rating in a report on Wednesday, January 31st. Three analysts have rated the stock with a sell rating, six have assigned a hold rating and eighteen have assigned a buy rating to the company. HCA Healthcare presently has an average rating of “Buy” and an average target price of $104.50.
HCA Healthcare Inc (NYSE HCA) opened at $102.58 on Wednesday. The company has a current ratio of 1.62, a quick ratio of 1.36 and a debt-to-equity ratio of -6.58. HCA Healthcare Inc has a 12-month low of $71.18 and a 12-month high of $106.84. The firm has a market capitalization of $36,236.03, a P/E ratio of 17.27, a PEG ratio of 1.03 and a beta of 0.49.
HCA Healthcare (NYSE:HCA) last issued its earnings results on Tuesday, January 30th. The company reported $2.12 earnings per share for the quarter, topping analysts’ consensus estimates of $1.87 by $0.25. HCA Healthcare had a negative return on equity of 49.49% and a net margin of 4.89%. The company had revenue of $11.56 billion for the quarter, compared to analyst estimates of $11.19 billion. During the same period in the prior year, the firm earned $1.80 earnings per share. HCA Healthcare’s revenue for the quarter was up 8.7% on a year-over-year basis. research analysts predict that HCA Healthcare Inc will post 8.71 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Friday, March 30th. Stockholders of record on Thursday, March 1st will be given a dividend of $0.35 per share. This represents a $1.40 dividend on an annualized basis and a dividend yield of 1.36%. The ex-dividend date is Wednesday, February 28th. HCA Healthcare’s payout ratio is 23.57%.
HCA Healthcare Profile
HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.